Atlas Trials

Ezetimibe-Ursodiol Combination Therapy on Biomarkers of Liver Function and Sterol Balance in Subjects With NAFLD

Clinical trial NCT02244944 · TERMINATED

Trial details

NCT number
NCT02244944
Sponsor
Gregory Graf, PhD
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Fatty Liver Disease (NAFLD)
Start date
2014-09-01
Primary completion
2015-09-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.